Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study |
| |
| Authors: | Bruna Cerbelli,Ilaria Girolami,Albino Eccher,Leopoldo Costarelli,Silvia Taccogna,Renzo Scialpi,Maria Benevolo,Teresa Lucante,Piero Luigi Al ,Francesca Stella,Maria Gemma Pignataro,Guido Fadda,Giuseppe Perrone,Giulia D&#x Amati,Maurizio Martini |
| |
| Affiliation: | Bruna Cerbelli,Ilaria Girolami,Albino Eccher,Leopoldo Costarelli,Silvia Taccogna,Renzo Scialpi,Maria Benevolo,Teresa Lucante,Piero Luigi Alò,Francesca Stella,Maria Gemma Pignataro,Guido Fadda,Giuseppe Perrone,Giulia D’Amati,Maurizio Martini |
| |
| Abstract: | |
| |
| Keywords: | 22C3 assay head and neck squamous carcinoma PD-L1 SP263 assay |
|
|
